Blockchain Registration Transaction Record
Telomir Pharmaceuticals Receives $3M Investment, Advances Key Drug Candidates
Telomir Pharmaceuticals receives $3 million investment from The Bayshore Trust, advancing key drug candidates Telomir-1 and Telomir-Ag2. CEO Erez Aminov emphasizes shareholder-friendly financing. IND submission for Telomir-1 planned by year-end. Visit the press release for more details.

This news matters as Telomir Pharmaceuticals secures a significant equity investment, showcasing confidence in its drug development pipeline. The company's focus on age-reversal and combating drug-resistant infections could have far-reaching implications for the healthcare industry and potential investors.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0x1496f12e4a11d44228932d41f93b88bb8ea7037f3761799d62945f5a04a6d79f |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | fastmcPm-d576f5460c9d37412ac76e85f019dc99 |